Polsinelli congratulates its client, Melitas Ventures, on its recent investment in Veracity as part of a $6 million financing round co-led by Maveron and Melitas. Veracity is a modern metabolic health company focused on addressing the root causes of metabolic dysfunction. The investment from Melitas will help Veracity fuel product innovation, scientific research and customer education.

More information about Melitas Ventures’ investment can be obtained from the following announcement.

The Polsinelli team involved in the transaction included Matt Weill and Claire Dugard.